Make us your home page

Today’s top headlines delivered to you daily.

(View our Privacy Policy)

Bristol-Myers Squibb resolves civil case

Florida will receive $21.5-million as its share of a global settlement with a pharmaceutical giant accused of illegal marketing and pricing of prescription drugs.

Among the allegations that led to the settlement was that Bristol-Myers Squibb illegally promoted the use of Abilify, one of a handful of new-generation antipsychotic drugs whose soaring use in children and nursing home residents has caused alarm among many mental health professionals.

Abilify and other atypical antipsychotics are FDA-approved to treat adult schizophrenia and bipolar disorder. But Abilify carries a black box warning concerning its use in the treatment of dementia. The government alleged Bristol-Myers Squibb created a specialized long-term care sales force that almost exclusively called on nursing homes, where dementia-related psychosis is far more common than schizophrenia or bipolar disorder.

And although Abilify was approved earlier this year for use in teens with schizophrenia and bipolar disorder, it was not approved for use in children between 2002 and 2005. That's when, the government alleged, the company directed its sales force to call on child psychiatrists and other pediatric specialists to urge them to prescribe Abilify to their pediatric patients.

In September, the Justice Department announced that Bristol-Myers Squibb and former subsidiary Apothecon Inc. agreed to pay more than $515-million to resolve "a broad array of civil allegations involving their drug marketing and pricing practices."

Among the other government allegations was that the company paid illegal kickbacks to physicians and other health care providers in the form of consulting fees, and advisory board positions — some of which involved travel to luxury resorts — to induce them to prescribe their drugs. The government also claimed the company set inflated prices for a wide assortment of oncology and generic drugs, and misrepresented its best price for an anti-depression drug, driving up costs to Medicaid.

The company admitted no wrongdoing.

Although the settlement with 44 states and the federal government was reached in September, disbursements to the state were made this week.

Bristol-Myers Squibb resolves civil case 07/16/08 [Last modified: Sunday, July 20, 2008 7:58am]
Photo reprints | Article reprints

© 2017 Tampa Bay Times


Join the discussion: Click to view comments, add yours

  1. Lightning takes defenseman Cal Foote with top pick in draft

    Lightning Strikes

    CHICAGO — Former Avalanche defenseman Adam Foote said his son Cal lived in the locker room.

    Cal Foote, second from left, is welcomed to the Lightning by GM Steve Yzerman, far left.
  2. It's Rays' turn to pound Orioles pitching (w/video)

    The Heater

    ST. PETERSBURG - Ah, the fantastic four.

    The Rays smashed the reeling Orioles 15-5 on Friday, scoring a season-high in runs, to climb four games above .500 for the first time since July 1, 2015.

    Rays third baseman Evan Longoria scores on a triple by Logan Morrison during the first inning against the Orioles.
  3. Lightning picks defenseman Cal Foote


    Cal Foote is the son of former Avs defenseman Adam Foote.
  4. Kids today: They don't work summer jobs the way they used to


    WASHINGTON — It was at Oregon's Timberline Lodge, later known as a setting in the horror movie The Shining, where Patrick Doyle earned his first real paycheck.

    Teens Ben Testa, from left, Hannah Waring and Abby McDonough, and Wegmeyer Farms owner Tyler Wegmeyer walk the strawberry rows at the Hamilton, Va., farm in late May.
  5. Jeb Bush back in the hunt for the Marlins, now opposing Derek Jeter


    Associated Press:

    Former Florida Gov. Jeb Bush has switched sides in pursuit of the Miami Marlins, and he’s trying to beat out former teammate Derek Jeter.